Condition: Respiratory Disease
Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
Abstract Recent studies have identified great similarities and interferences between the epithelial layers of the digestive tract, the airways and the cutaneous layer. The relationship between these structures seems to…
The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases
Abstract The global incidence of respiratory diseases and complications is increasing. Therefore, new methods of treatment, as well as prevention, need to be investigated. A group of compounds that should…
Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression
Please use this link to access this publication. Abstract Introduction: An escalating number of fatalities resulting from accidental opioid overdoses typically attributed to respiratory depression continue to define the opioid…
Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study
Abstract Introduction Although cannabis is frequently used worldwide, its impact on respiratory health is characterised by controversy. Objective To evaluate the association between cannabis use and respiratory-related emergency room (ER) visits and…
Inhaled D9 -tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression
Abstract Background: In humans, the effect of cannabis on ventilatory control is poorly studied, and consequently, the effect of D9 -tetrahydrocannabinol (THC) remains unknown, particularly when THC is combined…
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to coronavirus disease 2019 (COVID-19) which, in turn, may be associated with multiple organ dysfunction. In this review, we…